Ultra-low Temperature Freezers Market Size & Share 2026-2035

Ultra-low Temperature Freezers Market Size

The global ultra-low temperature freezers market was valued at USD 813.4 million in 2025 and is projected to grow from USD 849.6 million in 2026 to USD 1.5 billion by 2035, expanding at a CAGR of 6.3%, according to the latest report published by Global Market Insights Inc.

This substantial growth is driven by numerous factors, such as rising demand for biobanking and cryopreservation, advancements in vaccine storage, and growth in pharmaceutical and biotechnology research.

The ultra-low temperature freezers market encompasses all mechanical refrigeration units capable of maintaining temperatures typically between -40°C and -150°C,  specifically designed for the preservation and storage of sensitive biological materials, pharmaceutical compounds, and research specimens.

Leading companies in the ultra-low temperature freezers industry include Thermo Fisher Scientific, PHC Holdings Corporation, Haier Biomedical, Eppendorf AG, and Stirling Ultracold. These companies are strengthening their market position by advancing ultra-low temperature storage technologies across pharmaceutical, biobanking, and research applications. They are focusing on improving temperature stability, enhancing energy efficiency, and integrating smart monitoring systems to ensure reliable and compliant storage of critical biological samples and temperature-sensitive materials.

The market has increased from USD 726.2 million in 2022 and reached USD 780.8 million in 2024, with a historic growth rate of 3.7%. Growth in pharmaceutical and biotechnology research is a key driver for the ultra-low temperature (ULT) freezers market. As global investment in drug discovery, genomics, cell and gene therapy, and vaccine development continues to expand, there is an increasing need for reliable cold storage solutions to preserve sensitive biological materials. ULT freezers, typically operating at temperatures between -40°C and -86°C, are essential for maintaining the stability and integrity of samples such as DNA, RNA, proteins, and vaccines over extended periods. The surge in clinical trials and personalized medicine initiatives has further intensified the demand for precise temperature-controlled environments. Biopharmaceutical companies and research institutions require consistent storage conditions to ensure reproducibility and compliance with stringent regulatory standards. Additionally, the rising focus on biobanking and long-term sample archiving has contributed to widespread adoption of ULT freezers. Moreover, advancements in biologics and regenerative medicine, which rely heavily on temperature-sensitive materials, are reinforcing the importance of dependable cold storage infrastructure. As R&D activities continue to grow globally, the demand for high-performance, energy-efficient ULT freezers is expected to increase significantly.

Additionally, advancements in vaccine storage are a significant driver for the ultra-low temperature (ULT) freezers market, particularly with the rapid expansion of mRNA-based vaccines and therapies. According to Statista, the global mRNA vaccine and therapy market is projected to reach approximately USD 44.53 billion in 2025, reflecting strong growth in this segment. mRNA vaccines often require storage at ultra-low temperatures (typically between -70°C and -86°C) to maintain stability and efficacy, directly increasing the demand for advanced ULT freezers. As pharmaceutical companies scale up production and distribution of these temperature-sensitive vaccines, robust cold chain infrastructure becomes essential. This growing market value highlights the rising adoption of next-generation vaccines, thereby reinforcing the need for reliable, high-performance ULT storage systems worldwide.

Ultra-low Temperature Freezers Market Trends

• Innovations in energy-efficient ultra-low temperature (ULT) freezers are emerging as a key driver for market growth, as laboratories and biopharmaceutical companies increasingly prioritize sustainability. Traditional ULT freezers are highly energy-intensive, prompting the development of advanced models that significantly reduce power consumption while maintaining precise temperature stability.
• Manufacturers are integrating new compressor technologies, improved insulation materials, and eco-friendly refrigerants to enhance efficiency. These innovations not only lower operational costs but also help organizations meet stringent environmental and regulatory requirements, making modern ULT freezers more attractive to end users.
• Additionally, the incorporation of smart monitoring systems and IoT-enabled controls allows real-time energy optimization and predictive maintenance. This ensures reduced downtime and improved performance, further supporting adoption among research institutions and healthcare facilities aiming to streamline operations.
• As sustainability becomes a strategic priority across industries, energy-efficient ULT freezers are gaining strong traction. The combination of cost savings, regulatory compliance, and reduced carbon footprint is driving widespread replacement of older systems with next-generation, environmentally responsible solutions.

Ultra-low Temperature Freezers Market Analysis

Based on type, the ultra-low temperature freezers market is segmented into chest freezers, upright freezers, and other types. The upright freezers segment held the largest share of approximately 54.2% in 2025.

• The upright freezers segment holds the largest share in the ultra-low temperature freezers industry, driven by its space-efficient design and operational convenience in laboratory and healthcare settings. These systems are widely adopted across biobanks, pharmaceutical companies, and research institutions due to their vertical storage configuration, which enables organized sample management and easy accessibility. The increasing demand for sample integrity in applications such as vaccine storage, genomic research, and clinical trials continues to reinforce the adoption of upright freezers.
• Furthermore, technological advancements such as improved temperature uniformity, advanced insulation systems, and integration of digital monitoring solutions have strengthened the value proposition of upright freezers. Manufacturers are focusing on enhancing energy efficiency and incorporating smart diagnostic features to comply with stringent regulatory requirements. The ability to maintain consistent ultra-low temperatures with optimized storage footprints positions upright freezers as a preferred choice in high-throughput environments.
• The chest freezers segment accounted for USD 309.9 million in 2025. The chest freezers segment represents a significant portion of the ultra-low temperature freezers market, supported by its superior temperature stability and energy efficiency. These systems are widely utilized in applications requiring long-term storage of biological samples, reagents, and vaccines, where minimal temperature fluctuation is critical. Their design reduces cold air loss during door openings, making them suitable for facilities prioritizing thermal reliability over accessibility.

Based on application, the ultra-low temperature freezers industry is segmented into blood and blood products, organs & tissue preservation, pharmaceuticals & vaccines, forensic and genomic research, and other applications. The pharmaceuticals & vaccines segment held the largest share of 34.9% in 2025.

• The pharmaceuticals and vaccines segment is a key contributor to the ultra-low temperature freezers market, driven by the stringent storage requirements associated with biologics, specialty drugs, and temperature-sensitive vaccines. These freezers are widely used by pharmaceutical companies, research organizations, and distribution networks to ensure the stability and efficacy of products throughout the supply chain. The expansion of biologic drug pipelines and global immunization programs continues to support sustained demand.
• Furthermore, the increasing focus on cold chain logistics and compliance with regulatory guidelines has accelerated the adoption of advanced ultra-low temperature storage systems. The integration of real-time monitoring, data logging, and remote access capabilities enhances operational reliability and traceability. Growing investments in pharmaceutical research and global vaccine distribution infrastructure are expected to reinforce the segment’s growth trajectory.
• The blood and blood product segment accounted for USD 205 million in 2025. The blood and blood products segment holds a critical position in the ultra-low temperature freezers market, driven by the necessity for controlled storage conditions to maintain the viability and safety of blood components. Ultra-low temperature freezers are extensively used in blood banks and transfusion centers to preserve plasma, platelets, and rare blood types, ensuring compliance with stringent regulatory standards governing storage and handling. The increasing demand for blood donations and transfusion procedures continues to support the consistent utilization of these systems.
• Additionally, advancements in storage protocols and growing awareness regarding blood safety are contributing to the adoption of ultra-low temperature solutions in this segment.
• The organs and tissue preservation segment accounted for USD 117.9 million in 2025. The organs and tissue preservation segment represents a vital application area within the ultra-low temperature freezers market, supported by the increasing number of transplantation procedures globally. These systems play a crucial role in preserving biological integrity during storage and transportation, enabling extended viability of organs and tissues prior to surgical procedures. The demand for advanced preservation technologies continues to grow in parallel with advancements in regenerative medicine and transplant science.
• The forensic and genomic research segment accounted for USD 100.9 million in 2025. The forensic and genomic research segment is gaining importance in the ultra-low temperature freezers market due to the rising demand for precise and long-term storage of DNA samples, biological evidence, and genetic materials. These applications require strict temperature control to prevent degradation and ensure the integrity of samples used in investigative and analytical processes. The growing adoption of genomic sequencing and molecular diagnostics contributes significantly to segment expansion.

Based on capacity, the market is segmented into less than 300 liters, 301–700 liters, and above 700 liters. The 301–700 liters segment dominated the market with a share of 52.3% in 2025.

• The 301–700 liters segment holds the largest share in the ultra-low temperature freezers market, supported by its balanced capacity offering that meets the storage needs of mid- to large-scale laboratories and healthcare institutions. These systems provide an optimal combination of storage volume and operational efficiency, making them widely suitable for applications such as biobanking, pharmaceutical storage, and clinical research. Their versatility allows them to accommodate diverse sample types while maintaining consistent temperature control.
• Moreover, this segment benefits from ongoing advancements in energy efficiency, temperature uniformity, and smart monitoring capabilities. Manufacturers are increasingly integrating automated alarms, remote access features, and data logging systems to enhance compliance with regulatory standards. The expanding scope of research and diagnostic activities across institutions continues to reinforce the demand for medium-capacity ultra-low temperature freezers.
• The less than 300 liters segment accounted for significant revenue in 2025 and is anticipated to grow at a CAGR of 6.4% over the forecast period. The less than 300 liters segment represents a focused adoption category within the ultra-low temperature freezers market, primarily driven by its suitability for small-scale laboratories, clinics, and research facilities with limited storage requirements. These systems are designed to provide precise temperature control in compact configurations, enabling efficient storage of critical samples without requiring extensive floor space. Their applicability in decentralized healthcare settings and specialized research environments supports consistent demand.
• The above 700 liters segment accounted for significant revenue in 2025 and is anticipated to grow at a CAGR of 7% over the forecast period. The above 700 liters segment addresses the requirements of large-scale storage operations in industrial, pharmaceutical, and high-volume research facilities. These ultra-low temperature freezers are designed to support extensive sample storage with consistent thermal performance, making them essential for centralized biorepositories, vaccine storage hubs, and large clinical laboratories. Their ability to accommodate high storage volumes aligns with the increasing demand for bulk preservation of biological materials.
• Furthermore, the adoption of high-capacity systems is supported by advancements in cooling technologies, energy optimization, and system durability.

Based on end use, the ultra-low temperature freezers market is divided into pharmaceutical & biotechnology companies, biobanks, academic & research laboratories, hospitals & blood centers, contract research organizations (CROs), and other end users. The pharmaceutical & biotechnology companies segment accounted for the largest share of 37.5% in 2025.

• The pharmaceutical and biotechnology companies segment holds the largest share in the ultra-low temperature freezers industry, driven by the critical need for reliable storage of biologics, drug compounds, and clinical trial materials. These organizations extensively utilize ultra-low temperature freezers to maintain product stability and comply with stringent regulatory standards governing drug development and storage. The expansion of biologics pipelines and increased investment in advanced therapeutics continue to support sustained demand within this segment.
• Additionally, the integration of advanced monitoring systems, data tracking, and compliance-focused features enhances operational efficiency for pharmaceutical and biotechnology companies. The growing emphasis on precision medicine, gene therapy, and vaccine production further accelerates the adoption of ultra-low temperature storage solutions. Continuous advancements in cold storage technologies are enabling these organizations to optimize storage processes and ensure consistent product integrity.
• The academic and research laboratories segment is anticipated to grow at a CAGR of 5.9% over the forecast period. The academic and research laboratories segment plays a vital role in the ultra-low temperature freezers market, driven by extensive research activities across life sciences, biotechnology, and medical fields. These laboratories require consistent and precise temperature conditions to store experimental samples, reagents, and biological materials. The increasing number of research programs and funding initiatives supports the consistent adoption of ultra-low temperature freezers in academic institutions.
• The hospitals and blood centers segment accounted for significant revenue in 2025 and is anticipated to grow at a CAGR of 5.5% over the forecast period. The hospitals and blood centers segment is a key end-use category in the market, driven by the need for safe storage of blood products, vaccines, and other temperature-sensitive medical supplies. These facilities rely on ultra-low temperature freezers to maintain the quality and safety of stored materials, ensuring compliance with healthcare regulations. The growing demand for transfusion services and immunization programs supports continued utilization in this segment.
• The biobank segment is anticipated to grow at a CAGR of 6.1% over the forecast period. The biobank segment represents a significant application area in the ultra-low temperature freezers market, supported by the increasing establishment of large-scale biological sample repositories. Biobanks rely on ultra-low temperature freezers for the long-term preservation of biological specimens, including DNA, tissues, and cells, which are essential for research and clinical applications. The growth of population-based studies and personalized medicine initiatives continues to drive the expansion of this segment.

• Furthermore, advancements in sample management systems and growing investments in biobanking infrastructure are contributing to increased adoption.
  

North America Ultra-low Temperature Freezers Market

The North America region accounted for 42.1% of the global market in 2025. The ultra-low temperature freezers industry in North America is experiencing robust expansion.

• The U.S. market was valued at USD 130.1 million and USD 134.1 million in 2022 and 2023, respectively. The market size reached USD 144.2 billion in 2025, growing from USD 138.9 billion in 2024, and is anticipated to grow at a CAGR of 5.9% from 2026 to 2035.
• The increasing demand for biobanking and cryopreservation is a major factor supporting the growth of the ultra-low temperature freezers market in North America. The region has a well-established network of biobanks that require highly reliable storage systems for long-term preservation of biological specimens. These facilities depend on ultra-low temperature freezers to maintain sample integrity for research and clinical applications.
• Furthermore, the expansion of genomics, personalized medicine, and cell-based research is driving the need for advanced cryopreservation solutions. Ultra-low temperature freezers play a critical role in preserving DNA, tissues, and stem cells under controlled conditions. This growing research intensity is strengthening the adoption of advanced storage technologies across laboratories and research institutions.
• Strong funding support from government and private organizations for biobanking initiatives is accelerating infrastructure development. The presence of leading research institutions and healthcare systems further reinforces the demand for high-performance storage systems. This creates sustained opportunities for ultra-low temperature freezer deployment across North America.

Europe Ultra-low Temperature Freezers Market

Europe market accounted for USD 237.5 million in 2025 and is anticipated to show lucrative growth over the forecast period.

• Advancements in vaccine storage technologies are significantly driving the ultra-low temperature freezers industry in Europe. The region has experienced increased focus on maintaining stringent storage conditions for temperature-sensitive vaccines, particularly those requiring ultra-low temperature environments. This has led to strong demand for reliable and compliant freezer systems across healthcare and pharmaceutical sectors.
• Moreover, continuous improvements in cold chain logistics and storage protocols are enhancing vaccine distribution efficiency. Ultra-low temperature freezers equipped with advanced monitoring and alarm systems ensure consistent temperature maintenance during storage. These technological advancements are supporting large-scale immunization programs across the region.
• Additionally, regulatory emphasis on pharmaceutical storage standards and product safety is influencing the adoption of advanced freezer systems. European healthcare systems are investing in modern storage infrastructure to ensure vaccine efficacy and compliance. This ongoing development strengthens the role of ultra-low temperature freezers in the region’s vaccine supply chain.

Asia Pacific Ultra-low Temperature Freezers Market

The Asia Pacific region is projected to show a lucrative growth of about 6.7% during the forecast period.

• The growth in pharmaceutical and biotechnology research is a key driver for the ultra-low temperature freezers industry in Asia Pacific. The region is witnessing increasing investments in drug development, clinical trials, and biologics research, which require precise temperature-controlled storage solutions. Ultra-low temperature freezers are essential for maintaining the stability of research materials and biological samples.
• Furthermore, the expansion of research infrastructure and rising number of biotechnology firms are supporting market demand. Countries across the region are focusing on strengthening their research capabilities, leading to increased adoption of advanced laboratory equipment. This includes ultra-low temperature freezers for secure and long-term storage.
• Government initiatives promoting innovation in life sciences and healthcare are contributing to segment growth. The rising focus on vaccine development and biosimilar production further increases the need for efficient storage systems. These factors collectively drive the expansion of ultra-low temperature freezer utilization in Asia Pacific.

Latin America Ultra-low Temperature Freezers Market 

The Latin America market is experiencing robust growth over the analysis timeframe.

• Innovations in energy-efficient ultra-low temperature freezers are driving the market growth in Latin America. Increasing awareness regarding energy consumption and operational costs is encouraging the adoption of advanced freezer systems with optimized performance. Manufacturers are focusing on developing energy-efficient models that align with sustainability goals.
• Additionally, advancements in insulation materials, compressor technologies, and cooling systems are improving energy efficiency without compromising storage performance. These innovations enable end users to maintain consistent temperatures while reducing electricity usage. This is particularly relevant for facilities managing long-term storage operations.
• Moreover, the growing emphasis on environmental sustainability and regulatory compliance is influencing purchasing decisions across the region. Institutions are increasingly investing in modern, energy-efficient storage systems to improve operational efficiency. This trend is supporting the adoption of next-generation ultra-low temperature freezers in Latin America.

Middle East and Africa Ultra-low Temperature Freezers Market 

The Middle East and Africa (MEA) market is experiencing robust growth over the analysis timeframe.

• The rising demand for biobanking and cryopreservation is a significant driver for the ultra-low temperature freezers industry in the Middle East and Africa. The region is experiencing increasing efforts to establish biobanking infrastructure for research and clinical applications. Ultra-low temperature freezers are essential in preserving biological samples under stable conditions.
• Furthermore, the growth of healthcare research and the rising focus on genetic studies are contributing to the adoption of cryopreservation technologies. Research institutions and healthcare facilities require reliable storage solutions for maintaining sample integrity. This is supporting the deployment of advanced ultra-low temperature freezers.
• In addition, government initiatives aimed at strengthening healthcare systems and research capabilities are accelerating infrastructure development. The establishment of research centers and laboratories is creating demand for high-performance storage systems. This underpins the expansion of the ultra-low temperature freezers industry across the Middle East and Africa.

Ultra-low Temperature Freezers Market Share

• The top five players, Thermo Fisher Scientific, PHC Holdings Corporation, Haier Biomedical, Eppendorf AG, and Stirling Ultracold, collectively accounted for approximately 60% share of the global market, driven by strong technological capabilities, expanding cold storage infrastructure, advanced energy-efficient systems, and strategic collaborations across pharmaceutical, biobanking, and research institutions to support critical sample preservation applications.
• Ultra-low temperature freezer manufacturers, laboratory equipment providers, and research institutions are increasingly focusing on technological advancements to enhance storage reliability, temperature consistency, and operational efficiency. Key areas of development include advanced temperature control systems with real-time monitoring, integration of IoT-enabled diagnostics, and automated alarm mechanisms to ensure sample safety. In addition, innovations in compressor technology, insulation materials, and energy-efficient cooling systems are enabling improved performance and reduced operational costs. Continuous investments in high-performance systems, compact designs, and enhanced data management capabilities are supporting efficient deployment across biobanks, pharmaceutical facilities, hospitals, and research laboratories.
• Market participants, including manufacturer companies, healthcare institutions, and research organizations, are actively strengthening strategic collaborations to expand the application scope of ultra-low temperature freezers. Partnerships with hospitals, biobanks, and pharmaceutical companies are improving storage infrastructure and enhancing sample management capabilities. Furthermore, collaborations with academic and research institutions are supporting advancements in applications such as genomics, vaccine storage, and biologics preservation. These initiatives are improving storage accessibility, optimizing operational workflows, and supporting broader utilization of ultra-low temperature freezers across diverse end-use environments, thereby contributing to overall market growth.

Ultra-low Temperature Freezers Market Companies

Few of the prominent players operating in the ultra-low temperature freezers industry include:

• Arctiko A/S
• Avantor (VWR)
• B Medical Systems
• Eppendorf AG
• Esco Lifesciences
• Froilabo
• Haier Biomedical
• Helmer Scientific
• Labcold Ltd.
• NuAire Inc.
• PHC Holdings Corporation
• So-Low Environmental Equipment
• Stirling Ultracold
• Thermo Fisher Scientific
• Zhongke Meiling Cryogenics

• Eppendorf AG

Eppendorf AG strengthens its market presence through precision-engineered laboratory storage solutions, integration with advanced research workflows, and a strong focus on reliability and temperature stability to support sensitive biological sample preservation in research environments.

• Stirling Ultracold

Stirling Ultracold enhances its positioning through sustainable ultra-low temperature storage technologies, an emphasis on energy-efficient and environmentally compliant systems, and growing adoption across laboratories seeking advanced cooling performance with reduced operational impact.

Ultra-low Temperature Freezers Industry News:

• In February 2022, Medtronic plc received approval for its Freezor and Freezor Xtra cardiac cryoablation catheters from the U.S. FDA to treat pediatric patients suffering from atrioventricular nodal re-entrant tachycardia. This strategy broadened the company’s customer base, thereby augmenting its business revenue size.

The ultra-low temperature freezers market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2022 – 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Type

• Upright freezers
• Chest freezers
• Other types

Market, By Application

• Blood and blood products
• Organs & tissue preservation
• Pharmaceuticals & vaccines
• Forensic and genomic research
• Other applications

Market, By Capacity

• Less than 300 Liters
• 301-700 Liters
•  Above 700 Liters

Market, By End Use

• Pharmaceutical & biotechnology companies
• Bio-bank
• Academic & research laboratories
• Hospitals & blood centers
• Contract research organizations
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE